Disease Reporting Sample Clauses
The Disease Reporting clause requires parties to promptly notify relevant authorities or other parties if a disease outbreak or incident occurs that could impact the agreement. Typically, this clause outlines the specific diseases or symptoms that must be reported, the timeframe for notification, and the method of communication, such as written notice or electronic reporting. Its core function is to ensure timely information sharing, enabling swift response and mitigation measures to prevent further spread and manage associated risks.
Disease Reporting. The CONTRACTOR shall ensure that its providers comply with the disease reporting required by the A New Mexico Regulations Governing the Control of Disease and Conditions of Public Health Significance, 1980.
Disease Reporting. Percentage of reports of selected reportable diseases received by a public health department within the Measure Applies To Circumstances for Reporting Data May Be Taken From Other Considerations ☑ States ☑ Annual Requirement □ Incident □ Data Used By ☑ Directly Funded Localities (Excludes Chicago and Los Angeles County) □ If PHEP Funds Allocated to the Capability or Contracts Plan □ Exercise □ Data Collected By □ Territories or Freely Associated States □ Planned Event □ PAHPRA Benchmark Why is this measure important? Case reporting of reportable diseases is a prerequisite for an effective public health system. Timely reporting permits public health departments to initiate investigations and recommend meaningful interventions, thereby, protecting the health of individuals as well as the broader community. e-Incide The immediate intent of this performance measure is to capture the extent to which specific diseases of local and national public health significance are first reported to any level of the public health system (e.g., local, state, regional, county) from reporting entities (e.g., hospitals, labs, providers) within recipient-required timeframes. ore Publ Health The broader programmatic aim of this performance measure is to improve the timeliness of disease reporting by providers, hospitals, and laboratories to public health departments as part of systematic program and process improvement for health department surveillance programs.
Disease Reporting. Percentage of reports of selected reportable diseases received by a public health department within the Measure Applies To Circumstances for Reporting Data May Be Taken From Other Considerations States Annual Requirement □ Incident □ Data Utilized By Directly Funded Localities (Excludes Chicago and Los Angeles County) □ If PHEP Funds Allocated to the Capability or Contracts Plan □ Exercise □ Data Collected By □ Territories or Freely Associated States □ Planned Event □ PAHPRA Benchmark Why is this measure important? Case reporting of reportable diseases is a prerequisite for an effective public health system. Timely reporting permits public health departments to initiate investigations and recommend meaningful interventions, thereby, protecting the health of individuals as well as the broader community. The immediate intent of this performance measure is to capture the extent to which specific diseases of local and national public health significance are first reported to any level of the public health system (e.g., local, state, regional, county) from reporting entities (e.g., hospitals, labs, providers) within awardee-required timeframes. Pre-Incident The broader programmatic aim of this performance measure is to improve the timeliness of disease reporting by providers, hospitals, and laboratories to public health departments as part of systematic program and process improvement for health department surveillance programs. Response Awardees should report jurisdictionwide (e.g., statewide) performance measure data for PHEP 13.1. Awardees that are unable to report jurisdictionwide performance measure data should report as much data as feasible and indicate the percentage of the jurisdictional population covered by these data. Awardees are required to report data on case reports with CDC notification dates between Morbidity and Mortality Weekly Report (MMWR) Week 27, 2017 (beginning Sunday, July 9, 2017) through MMWR Week 26, 2018 (ending Saturday, June 30, 2018). Awardees are required to provide data on the following diseases according to the specified case classification criteria noted in parentheses: • Diseases associated with the following Category A agents: o Botulism (Clostridium botulinum), all types, excluding infant botulism (confirmed) o Tularemia (Francisella tularensis) (confirmed and probable)